Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
May 06, 2024 08:00 ET
|
Apogee Therapeutics, LLC
SAN FRANCISCO and WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...
Introducing Brillion, an AI-powered, customer-engagement application suite that enables utilities to scale and optimize energy efficiency, demand-side management (DSM) and clean energy programs, reflecting dynamic market needs
April 29, 2024 08:03 ET
|
Brillion
Utility SaaS provider Brillion launches today, offering an AI-powered customer engagement application suite built for electric, water, and gas utilities.
TRUGOLF RELEASES GROUNDBREAKING E6 APEX RANGE TRAINING SOFTWARE AND SIGNS JOE HALLETT, PGA COACH OF THE YEAR
April 08, 2024 09:00 ET
|
TruGolf Holdings, Inc.
SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc.(Nasdaq: TRUG) ("TruGolf”), among the leading sellers and distributors of golf simulator software and hardware, today...
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
April 03, 2024 07:30 ET
|
Oruka Therapeutics, Inc.
Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of care for patients with chronic skin diseases Oruka, the third company founded...
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
April 03, 2024 07:30 ET
|
ARCA biopharma, Inc.
Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of care for patients with chronic skin diseases Oruka, the third company...
Apogee Minerals Announces Amendment to Option Agreement for the Pine Channel Property
March 28, 2024 16:30 ET
|
Apogee Minerals Ltd.
Vancouver, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Apogee Minerals Ltd. (“Apogee” or the “Company” or the “Optionee”) (TSXV: APMI) has amended the option agreement (the “Amendment...
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
March 25, 2024 07:00 ET
|
Apogee Therapeutics, LLC
Preclinical data with APG808 demonstrate the potential for improved dosing over other treatment options in development, including the potential for dosing every six- or eight- weeks compared to dosing...
TRUGOLF ANNOUNCES NEWLY EXPANDED AI TECHNOLOGY LICENSING AGREEMENT WITH MLSPATIAL
March 20, 2024 09:00 ET
|
TruGolf Holdings, Inc.
SALT LAKE CITY, March 20, 2024 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (Nasdaq: TRUG) ("TruGolf”), among the leading sellers and distributors of golf simulator software and hardware, today...
Aluminum Curtain Wall Market To Reach USD 93.4 Billion By 2032 Report By DataHorizzon Research
March 12, 2024 19:30 ET
|
DataHorizzon Research
Fort Collins, Colorado, March 12, 2024 (GLOBE NEWSWIRE) -- The Aluminum Curtain Wall Market size was valued at USD 40.9 Billion in 2023 and is expected to have a market size of USD 93.4 Billion by...
Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million
March 12, 2024 16:01 ET
|
Apogee Therapeutics, LLC
SAN FRANCISCO, Calif. and WALTHAM, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company seeking to develop differentiated...